Author: Walti H. Monset-Couchard M.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.18, Iss.5, 1998-05, pp. : 321-337
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A Risk-Benefit Assessment of Therapies for Lennox-Gastaut Syndrome
By Schmidt D.
Drug Safety, Vol. 22, Iss. 6, 2000-06 ,pp. :
A Risk-Benefit Assessment of Drugs Used for Neonatal Chronic Lung Disease
Drug Safety, Vol. 22, Iss. 5, 2000-05 ,pp. :
A Risk-Benefit Assessment of Epoetin in the Management of Anaemia Associated with Cancer
By Beguin Y.
Drug Safety, Vol. 19, Iss. 4, 1998-10 ,pp. :